Researchers and leading Universities working with Bioventix antibodies are changing the world

A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer’s disease

6 October 2023

Abstract INTRODUCTION: Detection of Alzheimer’s disease (AD) pathophysiology among indi- viduals with mild cognitive changes and those experiencing subjective…

Levels of plasma brain-derived tau and p-tau181 in Alzheimer’s disease and rapidly progressive dementias

19 September 2023

Abstract INTRODUCTION: Rapidly progressive dementias (RPDs) are a group of neurolog- ical disorders characterized by a rapid cognitive decline….

Association of Serum Brain-Derived Tau With Clinical Outcome and Longitudinal Change in Patients With Severe Traumatic Brain Injury

3 July 2023

Abstract IMPORTANCE Blood-based measurements of total tau (T-tau) are commonly used to examine neuronal injury in patients with traumatic…

Preanalytical stability of plasma/serum brain-derived tau

25 April 2023

Abstract INTRODUCTION: We investigated the effects of matrix type and reagent batch changes on diagnostic performances and longitudinal trajectories…

Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration

27 December 2022

Abstract Blood-based biomarkers for amyloid beta and phosphorylated tau show good diagnostic accuracies and agreements with their corresponding CSF…

Performance of a Novel Research-Use-Only Secretoneurin ELISA in Patients with Suspected Acute Coronary Syndrome: Comparison with an Established Secretoneurin Radioimmunoassay

20 July 2021

Abstract Background: Circulating secretoneurin (SN) concentrations, as measured by established radioimmunoassay (RIA), risk stratify patients with cardiovascular disease. We…